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Biochemical characteristics of the RNase H activity 
associated with immunoaffinity purified human im- 
munodeficiency virus (HIV) reverse transcriptase (RT) 
were examined. Glycerol gradient centrifugation of 
HIV  RT resulted in a single peak of RNase H, associ- 
ated with RT activity, with an apparent molecular 
weight of 110,000. HIV RNase H exhibited a marked 
substrate preference for poly(dC)*[SH]poly(rG) com- 
pared to p~ly(dT).[~H]poly(rA). It did not hydrolyze 
single-stranded RNA or the DNA  component of 
DNA-RNA hybrids. Products of the HIV RT-associated 
RNase H reaction consisted primarily of monomers, 
dimers, and trimers with 3’ OH groups. This reaction 
was Mg2+ dependent, with greater than 90% of maxi- 
mum activity at MgClz concentrations between 4 and 
12 mM. The optimum KC1 concentration for HIV RNase 
H was 50 mM, which was lower than that for HIV RT 
catalyzed polymerization with a poly(rA)*(dT)lo tem- 
plate. The optimum pH for HIV RNase H activity  was 
between 8.0 and 8.5, in contrast to an optimum pH of 
7.5 to 8.0 for HIV  RT activity. The association of 
RNase H activity  with the p66 component  of HIV  RT 
was demonstrated by activity  gel  analysis. These re- 
sults indicate that HIV RT has an integral RNase H 
activity;  however, some of  its properties are  different 
from those of RNase H associated with other retroviral 
RT’s,  and optimal assay conditions are  different than 
those for HIV RT catalyzed DNA polymerization. 
The human immunodeficiency virus (HIV)’ genome, like 
that of other retroviruses, contains  three major genes, desig- 
nated gag, pol, and env (1). The pol gene, thought to be 
expressed by fusion of gag and pol reading frames, codes for 
at least three  distinct  proteins. By analogy with similar vi- 
ruses, these include a  protease which is responsible for proc- 
essing of precursor polypeptides, a reverse transcriptase (RT) 
which synthesizes a double-strand DNA copy of the viral 
ribonucleic acid  genome, and  an endonuclease/integrase (2). 
RT catalyzes several enzymatic reactions, including both 
RNA- and DNA-directed DNA polymerization (2, 3). In  ad- 
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dition, retroviral RT typically catalyzes hydrolysis of the RNA 
component of DNA. RNA hybrids, known as RNase H activ- 
ity (2). 
HIV RT is composed of two polypeptides, p66 and p51, 
which share  a common amino terminus (4, 5). p51 is derived 
from the proteolytic cleavage of p66, with release of a small 
polypeptide, p15 (6,7).  This processing is thought to result in 
production of a stable p66/p51 dimer, which may be the 
natural form of HIV RT (8). However, after  separation of p66 
and p51 by denaturing polyacrylamide gel electrophoresis, p66 
can renature, with recovery of DNA- and RNA-dependent 
DNA polymerase activity, but recovery of p51 catalytic activ- 
ity is  very poor in comparison (3). 
Amino acid sequence analysis of retroviral pol genes sug- 
gests that polymerase sequences are  present within the amino- 
terminal portion of p66,  while the carboxyl terminus is ho- 
mologous with RNase H from Escherichia coli (9). The asso- 
ciation of RNase H activity with HIV RT produced by expres- 
sion of a recombinant gene in E. coli (lo), and with RT from 
lysed virions (6), was recently reported. RNase H and RT 
activity co-purify during ion exchange and DNA affinity 
chromatography, as well as glycerol gradient centrifugation. 
In addition, proteolytic processing of p66 results  in production 
of p51 and a small polypeptide (p15) that retains RNase H 
activity but lacks polymerase activity (6). 
There  are several possible functions of RNase H in proviral 
DNA synthesis. These include removal of 5’ genome  RNA in 
DNA.RNA after strong stop minus-strand DNA synthesis, 
removal of the tRNA primer at  the 5’ end of minus-strand 
DNA, and  a role in generation of the primer for plus-strand 
DNA synthesis (2). In view  of the importance of RNase H  in 
the generation of proviral DNA, this enzyme activity is a 
possible chemotherapeutic target for inhibition of HIV repli- 
cation. This  article examines some of the biochemical char- 
acteristics of the RNase H activity associated with immu- 
noaffinity purified HIV RT. 
MATERIALS  AND  METHODS 
PoMdC), poly(dT), oligo(dT)12-ls, poly(rC) .(dG)12.18, poly(dC). 
(dG)12-18, poly(rA), (dT),,, E. coli RNA polymerase, phosphodiesterase 
I, Sephadex G-50, and unlabeled nucleotides were purchased from 
Pharmacia  LKB Biotechnology, Inc. (Piscataway, NJ). Moloney mu- 
rine leukemia virus (MMLV) RT, E. coli RNase  H, T4 polynucleotide 
kinase, urea, and ultrapure reagents for polyacrylamide gel electro- 
phoresis (PAGE) were obtained from Bethesda Research Laborato- 
ries (Gaithersburg, MD). Gel filtration molecular weight standards, 
bovine serum albumin (BSA), guanylyl-(3’-5’)guanosine (GpG), and 
calf thymus DNA  were acquired from Sigma. Avian myeloblastosis 
virus (AMV) RT and dithiothreitol (DTT) were purchased from 
Boehringer Mannheim. ACS scintillation mixture was obtained from 
Amersham Corp. Molecular weight markers for denaturing PAGE 
and a 4-chloro-1-naphthol containing horseradish peroxidase color 
development reagent were acquired from Bio-Rad. Biotinylated anti- 
human IgG and avidin D-horseradish peroxidase conjugate were 
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purchased from Vector Laboratories, Inc. (Burlingame, CA). All 3H- 
and 32P-labeled compounds were purchased from ICN Radiochemicals 
(Irvine, CA). 
HIV positive human serum and immunoaffinity purified HIV RT 
were kindly provided by Biotech Research Laboratories (Rockville, 
MD). 7.5  ml  of lysed virions from HTLV-IIIb-infected H9 cell culture 
supernatant was applied to a 10-ml affinity column, which consisted 
of monoclonal antibody specific for HIV p66 and p51 covalently 
linked to Sepharose (5). The column was washed with 275 ml of 
phosphate-buffered saline, then with 30 ml of phosphate-buffered 
saline with 0.5 M NaCl, followed by elution with 40 ml of 0.2 M 
NHIOH. Fractions of 3 ml were collected during elution, and were 
neutralized by addition of an equal volume of  0.5 M Tris-HC1, pH 6.8. 
Fractions which corresponded to  the peak of RT activity were  pooled, 
and BSA was added to a final concentration of 100 pglml. Pooled 
enzyme was dialyzed against 50 mM Tris-HC1, pH 7.5, 2 mM DTT, 
20%  glycerol, and was stored at  -70 "C. General properties of this 
enzyme preparation have been described (11). 
Substrate  Preparation 
Poly(dT). pHlpoly(rA) and Poly(dC). pH]poly(rG-These com- 
plexes were synthesized with E. coli  RNA polymerase and  the respec- 
tive DNA homopolymer. Reaction mixtures (250 pl) contained 50 
mM Tris-HC1, pH 7.8, 100 mM KC1, 5 mM MgC12, 1 mM MnClZ, 5 
mM DTT, 5% glycerol, and 1 AZM) unit of poly(dT) with 500 p M  [3H] 
ATP (2 Ci/mmol), or 1 A260 unit of poly(dC) with 500 p M  [3H]GTP 
(2 Ci/mmol). These were prewarmed to 37 "C, and reactions were 
initiated with 20-70 units of E. coli  RNA polymerase. After 10 min, 
reactions were terminated with 10 p1 of 0.5 M EDTA, and products 
were separated from free nucleotides by chromatography on 1.5-ml 
Sephadex G-50 columns. Peak void  volume fractions were  pooled and 
extracted with an equal volume of phenyl/chloroform/isoamyl alcohol 
(1:1:0.04). The aqueous phase was precipitated with 2 volumes of 
100% ethanol, and  the precipitate was resuspended in sterile HzO. 
Poly(dC). ~2P]poly(rG)-This was prepared in  a reaction identical 
to  that described above except that  the reaction volume was 50 p1 
and contained 0.2  A260 units of poly(dC) and 500 p M  [w3'P]GTP (10 
Ci/mmol). 
DNA. L3H]RNA-The complex  was prepared as described above 
in a 50-p1 reaction which contained 10 pg of heat-denatured calf 
thymus DNA and 500 pM (2 Ci/mmol) of each rNTP. A portion of 
the purified DNA. [3H]RNA was heat denatured by incubation at 
80 "C for 15 min followed  by immediate cooling  on  ice. 
PHIDNA. RNA-This  was prepared with the use of MMLV RT 
in a reaction which contained the same buffers and  salts as for E. coli 
RNA polymerase reactions, and 10 pg of poly(A)+ RNA (prepared 
from KB cells as described in Ref. 12),  5 pg  of oligo(dT)m18,  500 p M  
(2 Ci/mmol) of each t3H]dNTP,  and 20 units MMLV RT. 
Enzyme Assays 
DNA- and RNA-dependent DNA Polymerase-Standard reaction 
mixtures (50 pl) contained 50 mM Tris-HC1, pH  8.0,2 mM DTT, 100 
pg/ml BSA,  100 mM KC1,8 mM MgClz; 0.5 AZm units/ml of poly(rA). 
(dTh,  poly(rC). (dG)lZ-la, or poly(dC). (dG)L2-ls; and 10 p M  (20 pCi/ 
ml) of [3H]TTP or [3H]dGTP. Reactions were initiated with 2-5 pl 
of enzyme and incubated at 37 "C for 30 min. 40-pl aliquots were 
spotted on glass fiber filters (Whatman GF/A) and processed for 
determination of trichloroacetic acid-insoluble radioactivity. One unit 
is defined as the amount of enzyme which catalyzes incorporation of 
1 nmol of deoxynucleotide/h into acid-insoluble material. Unless 
otherwise stated, units of RT were determined with a  poly(rA). ( d T h  
template using standard reaction conditions. 
Tris-HCI, pH 8.0, 2 mM DTT, 100 pg/ml BSA, 50 mM KC1, 8 mM 
RNase H-Standard reaction mixtures (50 pl) contained 50 mM 
MgClZ, and 2 X lo' cpm of 3H-labeled substrate (poly(dC).[3H] 
poly(rG) unless otherwise indicated). Reactions were initiated with 
2-5 pl  of  enzyme and incubated at 37 "C for  30 min. Reactions were 
terminated by transfer  to wet  ice  followed  by addition of  50 pl of ice- 
cold 7% perchloric acid. After 30 min on ice, precipitate was pelleted 
by centrifugation at 10,000 rpm for 15 min. 75 pl of the  supernatant 
was added to 10 ml of scintillation mixture. One unit is defined as 
the amount of  enzyme  which produces 1 nmol of acid-soluble ribo- 
nucleotide/h at 37 "C. 
Glycerol Gradient Centrifugation 
Tris-HC1, pH 7.5,  1 mM DTT,  and 200 mM KC1 in  a  total volume of 
Continuous 10-30% glycerol gradients which contained 25 mM 
4.8 ml  were prepared. 60 units of HIV RT in a  final volume of  200 pl 
(10% glycerol) was layered onto the top of the gradient. Identical 
gradients were layered with solution containing molecular weight 
standards (20 pg each)  in buffer containing 10% glycerol. Ultracen- 
trifugation was performed at  4  "C for 20 h a t  40,000 rpm in  a Beckman 
SW 50.1 rotor. Fractions of approximately 200  pl each were collected 
from the top of the gradient and assayed for the presence of various 
enzyme activities as described above. Positions of molecular weight 
standards were identified after PAGE in the presence of sodium 
dodecyl sulfate  (SDS) as previously described (13), followed  by stain- 
ing with Coomassie Blue (14). Recovery of all enzyme activities was 
greater than 80%. 
Product Analysis 
0.05 or 0.5 units of HIV RNase H were incubated with poly(dC) . 
[32P]poly(rG) using standard reaction conditions for the time periods 
indicated in Fig.  2. Two 10-pl portions of each reaction were treated 
with 10 pl of 7% perchloric acid and processed for determination of 
acid-soluble radioactivity as described above. One 5-pl portion of each 
reaction was diluted with 20 pl of H20  and 12.5 p1 of sequencing gel 
sample buffer (50 mM EDTA and 0.02% bromphenol blue in 88% 
formamide). 5 pl of an 80% acid-soluble reaction was further  treated 
for 15 min with 0.1 unit of phosphodiesterase I at 37 "C, followed  by 
addition of 44 pl of H20 and 25 p1 of sequencing gel sample buffer. 
[5'-32P]GpG was prepared by 5' phosphorylation of GpG with T4 
polynucleotide kinase in the presence of [-y-32P]ATP as recommended 
by the kinase supplier. Part of the [5'-32P]GpG was treated with 
phosphodiesterase I to produce [5'-32P]GMP. Samples were boiled 
for 5 min and fractionated by electrophoresis on a 15% polyacryl- 
amide-urea DNA sequencing gel as previously described (15), followed 
by autoradiography with Kodak X-Omat  K film. 
RNase H Actiuity Gel 
A 10% polyacrylamide gel which contained SDS was prepared 
essentially as described by Laemmli (13), except for the addition of 
poly(dC). [32P]poly(rG) (IO6 cpm) prior to polymerization. Enzyme 
samples for activity recovery were HIV RT (12 units), MMLV RT 
(200 units), and E. coli RNase  H (10 units), each in  a final volume of 
40 p1 which contained 5% glycerol, 2 mM EDTA, 1% SDS, 50 mM 
Tris-HCl,  pH 7.5,0.02% bromphenol blue, 1 mg/ml BSA, and 0.5 mM 
2-mercaptoethanol. These were incubated for 5 min at  37 "C before 
application to  the gel. One lane was reserved for protein standards 
and another for HIV RT transfer to nitrocellulose. These were  mixed 
with standard sample buffer (13) and boiled before application to  the 
gel. After electrophoresis, the lane with molecular weight standards 
was  removed and stained with Coomassie Blue (14). The lane with 
HIV RT in standard sample buffer was transferred to nitrocellulose 
(16), and transferred  proteins were stained by incubation with human 
HIV positive serum, followed by biotinylated anti-human IgG, and 
avidin D-horseradish peroxidase conjugate, in a blocking buffer which 
consisted of 5% Carnation non-fat dry milk and 4% IgG-free calf 
serum in phosphate-buffered saline. Development was performed with 
a 4-chloro-1-naphthol-based reagent in the presence of HZOZ as rec- 
ommended by the horseradish peroxidase substrate supplier. 
The remainder of the gel, which contained enzymes for activity 
recovery,  was shaken gently at room temperature for 1 h in 2 changes 
(1 liter each) of 50 mM Tris-HC1, pH 8.0, 2 mM DTT, 20%  glycerol, 
followed  by 16 h in 2 changes (1 liter each) of the same buffer  plus 
50 mM KC1 and 8 mM MgCL The gel was shaken for another 8 h  in 
two changes (I liter  each) of 50 mM Tris-HC1, pH 8.0,  50 mM KC1, 2 
mM DTT, 8 mM MgC12, in the absence of glycerol,  followed by 16 h 
in the same buffer at 37 "C without shaking. This was followed by 
gentle shaking for 4  h  in 4 (1 liter) changes of cold 5% trichloroacetic 
acid, 10 mM pyrophosphate. The gel was dried under vacuum and 
autoradiography was performed with Kodak X-Omat K film. 
RESULTS 
Glycerol Gradient Centrifugation-Immunoaffinity purified 
HIV RT was subjected to ultracentrifugation in a 10-30% 
glycerol gradient in the presence of 200 mM  KC1, and  fractions 
were analyzed for the presence of polymerase and RNase H 
activities (Fig. 1). A single peak of RNase H activity was 
coincident with DNA polymerase activity measured with a 
poly(dC) .oligo(dG) template,  and with RT activity measured 
with poly(rC) . oligo(dG) and poly(rA) .oligo(dT) templates. 








FIG. 1. Glycerol gradient centrifugation of HIV RT. Ultra- 
centrifugation of immunoaffinity purified HIV RT was performed as 
described under “Materials and Methods.” Fractions of approxi- 
mately 200 p1 were collected from the  top of the gradient and assayed 
for the presence of RNase H  activity (O), or for polymerase activity 
with a poly(rA). ( d T h  (m), poly(rC). (dG)12-la (A), or poly(dC). 
(dG)12.18 (e) template. Positions of standard  proteins  are indicated 
with arrous: carbonic anhydrase (29,000), BSA (66,000), alcohol 
dehydrogenase (150,000), and &amylase (200,000). 
TABLE I 
Substrate preference of RNase H activity associated with HIV and 
AMV reverse transcriotase 
Substrate HIV RT” AMV RT” 
DNA.[3H]RNA 0.026 0.032 
DNA. [3H]RNA, heat-denatured 0 
RNA. [3H]DNA 0 
Poly(dT) . [3H]poly(rA) 0.004  0.056 
Poly(dC). [3H]poly(rG) 0.150 0.033 
a Labeled substrate rendered acid-soluble (nanomole/h) per  unit 
of RT. Nuclease activity  with the indicated substrate was plotted as 
a function of RT activity, and  the slope was determined by linear 
regression analysis. Numbers represent the average slope from a t  
least two such  experiments,  each  with a t  least  four  different enzyme 
concentrations. The lowest average correlation coefficient was 0.934. 
The complex had  an  apparent molecular weight of approxi- 
mately 110,000. When  a  similar  experiment was conducted in 
the absence of KCl, a broad peak of polymerase and RNase 
H activity appeared  in  fractions 11-21, which corresponded 
to  apparent molecular weights between 110,000 and 250,000 
(data  not shown). 
Template Preference of HZV RNase H-HIV RT-associated 
RNase exhibited a  marked substrate preference for poly(dC). 
[‘H]poly(rG) compared to  poly(dT). [3H]poly(rA),  in contrast 
with AMV RT/RNase H which preferred the  latter  substrate 
(Table I). Intermediate  activity was obtained with HIV RNase 
H and a mixed DNA. [3H]RNA hybrid. There was an absence 
of nonspecific nuclease activity  in  our  preparation of HIV RT 
as demonstrated by the lack of degradation of single-stranded 
RNA, and  an inability to hydrolyze [3H]DNA in  a  [3H]DNA. 
RNA hybrid. 
Products of the HZV RNase H Reaction-HIV RT/RNase 
H was incubated with poly(dC) . [32P]p~ly(rG) under standard 
conditions, and the reaction products were identified after 
a b  c d e f q h  
“ 
GMP- 
FIG. 2. Products of the HIV RNase H reaction. Products of 
the HIV RNase  H  reaction with a poly(dC). [“P]poly(rG) substrate 
were analyzed as described under  “Materials and Methods.” Lanes a 
and b contain 5’-3’P-labeled pGpG and  GMP, respectively. Lane c is 
a  control  reaction,  incubated for 40 min at  37 “C in the absence of 
enzyme. Lunes d,  e, and f are reactions with 0.05 units of HIV RNase 
H  incubated for 20, 40, and 120 min, respectively. Lane g contains 
reaction  products from a 120-min incubation with 0.5 units of HIV 
RNase  H. The percentages of acid-soluble material in lanes d-f were 
30,54,80,  and 100%. Lune h contains one-half the  amount of reaction 
products in lane f ,  treated with venom phosphodiesterase as described 
under “Materials  and Methods.” 
MgC12 (mM) 
FIG. 3. MgCI, dependence  of HIV RT and RNase H activi- 
ties. HIV RT (W) and RNase  H (0) activities were measured using 
standard reaction conditions, except that MgCI, was added at  the 
indicated final concentrations. Data points represent the average 
values from two experiments, each performed in duplicate. 
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KC1 (mM) 
FIG. 4. Effect of KC1 on HIV RT and RNase H activities. 
HIV RNase  H (0) and polymerase activities  with poly(dC). (dG),2-,8 
(A) and  poly(rA).  (dT),o (W) templates were measured  using standard 
assay  conditions,  except that KC1 was added at   the indicated  final 
concentrations. Each data point represents the average of at  least 
three  determinations f standard deviation. 
6001 
, . . . . .  
TRlS 
HEPES 
6.0 65  7.0 7.5 8.0 8.5 
pH 
FIG. 5. pH profile of HIV RT  and RNase H activities. HIV 
R T  (W) and RNase H (0) activities were measured using standard 
reaction  conditions  except that  Tris (- - - -) or Hepes (-) buffers, 
adjusted a t  37 "C to the indicated pH, were substituted for the 
standard buffer. 
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FIG. 6. RNase H activity  gel. A polyacrylamide gel with  incor- 
porated poly(dC).["P]poly(rG) was prepared and processed as de- 
scribed under  "Materials and Methods." A shows the immunostain 
pattern of HIV RT after transfer to nitrocellulose. The RNase H 
activity gel in B contains ( a )  HIV RT, ( b )  MML  RT,  and (c )  E. coli 
RNase H. 
electrophoresis  in a  polyacrylamide/urea DNA  sequencing gel 
(Fig. 2).  Incubation  with 0.05 units of R T  for 20,  40, or 120 
min  resulted  in  the  increasing  appearance of a series of 32P- 
labeled oligomers, primarily  monomers, dimers, and  trimers. 
80% of the  substrate was  acid-soluble at 120  min. When a 10- 
fold higher concentration of HIV R T  was employed,  100% of 
the substrate was rendered acid soluble, and the products 
consisted almost exclusively of monomers, dimers, and tri- 
mers. Treatment of HIV RNase H reaction products with 
venom phosphodiesterase  resulted  in complete  conversion to 
[5'-"P]GMP. 
Divalent  Cation  Requirement-The HIV  RNase H  reaction 
with poly(dC) . [3H]poly(rG)  as  the  substrate was absolutely 
dependent on the presence of divalent cation. MgC12 was 
preferred to MnC12 (not shown). Greater than 90% of the 
maximum RNase H activity was obtained a t  MgClz concen- 
trations between 4 and 12 mM (Fig. 3). This is in  contrast  to 
the MgC12 dependence of HIV R T  activity measured  with  a 
poly(rA). (dT)lo template, which exhibited a comparatively 
sharp MgC12 optimum of  6-8  mM, and  retained only  54% of 
maximum activity a t  a concentration of 12 mM. 
Effect of Salt-The  effect of  KC1 on  RNase H  activity and 
on polymerase activity  with several different  templates was 
examined (Fig. 4). KC1 was added  to various assay  mixtures 
at 25 mM increments  to 0.25 M. R T  activity with  a  poly(rA) . 
(dT)lo  template  exhibited a  maximum activation of about 2.3- 
fold a t  75 mM KC1, and KC1 concentrations  greater  than 175 
mM resulted  in less activity  than observed in  the absence of 
KCl. This was similar to  the  salt  activation profile observed 
with a poly(rC) . (dG)l,-la template  (not shown). In  contrast, 
DNA polymerase activity with poly(dC) . (dG)12-18 retained 
164% of control activity in the presence of 250 mM KCl. 
RNase H activity  exhibited a salt profile different from that 
of polymerase activity  with  any of these  templates. Maximum 
activation of 2.1-fold was obtained a t  50 mM KCl, and  the 
presence of  KC1 at concentrations  greater  than 100 mM was 
strongly  inhibitory. 
pH Optimum-HIV RT-associated  RNase H had  an  alka- 
line  pH  optimum of  8.0-8.5, with  either  Tris  or  Hepes buffers 
(Fig. 5). In contrast, polymerase activity with a poly(rA). 
(dT),o template  had a sharp  pH  optimum between 7.5 and 
8.0, and  retained  about 60% of maximum activity a t   pH 8.5. 
RNase H Activity Gel-The RNase H substrate poly(dC) . 
[32P]poly(rG) was incorporated  into a polyacrylamide gel prior 
to polymerization. Purified  HIV R T  was denatured  and  sub- 
units were separated  during electrophoresis through  this gel. 
One  lane which contained  HIV R T  was transferred  to  nitro- 
cellulose and immunostained with a monoclonal antibody 
against  this  enzyme (Fig. 6a).  The  remainder of the gel was 
washed  extensively to allow protein  renaturation, followed by 
incubation a t  37 "C under  conditions  optimal for detection of 
HIV  RNase H activity. The gel was then dried, and  autora- 
diography performed (Fig. 6b).  RNase H activity was associ- 
ated  with  the p66 subunit of HIV R T  as demonstrated by the 
absence of radioactive substrate in the portion of the gel 
occupied by p66. A smaller  band of nuclease activity which 
corresponded to a molecular  weight of approximately 200,000 
was also noted. 
DISCUSSION 
Immunoaffinity purified HIV R T  possessed RNase H  activ- 
ity  as well as  DNA-  and  RNA-dependent DNA polymerase 
activity. All three  activities co-migrated in a glycerol gradient 
during ultracentrifugation. We were unable to observe any 
small molecular  weight RNase H in glycerol gradient  fractions 
or by activity gel analysis. RNase H activity was an integral 
part of HIV  RT,  since  it  was as ociated with  the p66 subunit. 
A smaller amount of RNase H activity with an apparent 
molecular  weight of 200,000 was  also  observed, which raises 
the interesting possibility that  the gag-pol precursor could 
have  RNase H  activity; however, we have not ruled out  the 
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possibility that  the presence of high molecular weight RNase 
H could be due to enzyme aggregation. Others have observed 
concurrent production of p51  and  a 15,000 RNase H  during 
proteolytic cleavage of a carboxyl-terminal fragment from  p66 
(6). Several factors may contribute t o  the absence of this 
activity in our preparation. The monoclonal antibody used 
for purification of HIV RT recognizes a  determinant  shared 
by p66 and p51, and would not be expected to recognize the 
carboxyl-terminal portion of p66. Therefore, p15 should not 
be present unless it forms  a complex with RT, or is produced 
after purification of RT by the action of a contaminating 
protease. 
HIV RT-associated RNase H  demonstrated  characteristics 
of a  true RNase H, since it did not degrade single-stranded 
RNA or the DNA portion of a DNA.RNA hybrid. Unlike 
AMV RT,  it demonstrated  a marked substrate preference for 
poly(dC) . [3H]poly(rG).  In  addition, we have confirmed the 
substrate  potential of mixed DNA. [3H]RNA hybrids observed 
by others (6, 10). However, poly(dC)- [3H]poly(rG) is the 
preferred substrate for many applications due to higher activ- 
ity, ease of preparation,  and homogeneity of the substrate. 
Like AMV RT/RNase H, HIV RT-associated RNase H 
produced a series of oligomers;  however, these  products  are 
primarily monomers, dimers, and  trimers, while AMV RNase 
H  products  are primarily larger oligonucleotides (2, 17). 
Venom phosphodiesterase was able to convert HIV RNase H 
products to [5’-32P]GMP. Since this enzyme requires a  sub- 
strate with a free 3’-hydroxyl group,  HIV RNase H products, 
like those produced by other retroviral RNase Hs (2), are 
probably terminated with 5’-phosphate  and 3”hydroxyl 
groups. 
Several factors indicate that HIV RT contains distinct 
catalytic  sites for polymerase and RNase H activity. Amino 
acid sequence analysis demonstrates homology with viral and 
bacterial polymerases within the amino-terminal  portion of 
p66, and homology with other RNase Hs near the carboxyl 
terminus (9). Release of an active 15,000 RNase H which 
lacks polymerase activity during processing of p66 also sup- 
ports  this idea (6). Proteolytic fragments of  AMV RT which 
possess RNase H activity but lack polymerase activity have 
also been reported (18). In spite of apparently  distinct active 
sites for RNase H and polymerase, removal of the 15,000 
fragment results in a 51,000 polypeptide that has greatly 
reduced RT activity. We previously reported that we were 
unable to detect polymerase activity associated with p51 by 
activity gel analysis (3); however, with highly concentrated 
enzyme, we are now able to detect  a small amount of p51- 
associated polymerase activity. This is consistent with a re- 
cent  report that p51  has 20-80-fold less RT activity than p66/ 
mg  of protein (19). 
RNase H activity catalyzed by p15 H exhibits a random 
mode of action, in contrast with RT-associated RNase H, 
which is processive (6). The change to a random mode of 
RNase H action after loss of the polymerase active site could 
be due to  the loss of a nucleic acid binding domain. That  this 
is the case for HIV p15 is  supported by a site-directed muta- 
genesis study which indicates that  the template binding site 
is  present within the amino-terminal half of p66 (20). 
Our results obtained with immunoaffinity purified HIV RT 
indicate several differences in optimum assay conditions for 
polymerase and RNase H activities. RNase H exhibits a 
broader MgClz optimum, lower KC1 optimum, and  prefers  a 
more alkaline pH, than polymerase. For these reasons and 
those discussed above, it may  be possible to discover selective 
inhibitors of HIV RNase H. 
RNase H plays an important role in proviral DNA synthesis 
catalyzed by RT.  Studies in progress may indicate whether or 
not  this enzyme activity will be a useful target for inhibition 
of HIV replication. In addition, degradation of viral genomic 
or messenger RNA  by RNase H could be an  important mech- 
anism of action of antisense oligonucleotides, a  chemothera- 
peutic approach which  is under active investigation in several 
laboratories. This article provides important basic informa- 
tion for investigation of these possibilities. 
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